NCT07183696 Respiratory Muscle Training and Quality of Life in Hemodialysis Patients
| NCT ID | NCT07183696 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Hemodialysis |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-10-01 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the effect of breath booster training on respiratory muscle strength and quality of life in patients undergoing hemodialysis. It aims to determine whether targeted respiratory training can improve pulmonary function, enhance physical performance, and positively impact overall well-being in this population.
Eligibility Criteria
Inclusion Criteria: 1. Fifty patients will be included in this study. 2. Their ages will range from 50 to 60 years. 3. Patients with end-stage renal disease (grade 5) receiving hemodialysis. 4. Patients on hemodialysis for around 1 to 3 years. 5. They will be able to follow instructions during evaluation and treatment. Exclusion Criteria: 1. Diabetes Mellitus, 2. Morbid obesity with a BMI of more than 35 kg/m2. 3. Hearing or visual impairments. 4. Any severe chest diseases like COPD. 5. Certain contraindications for the use of the Breath Booster. Individuals with severe respiratory conditions such as unstable asthma, or emphysema, or those who have recently undergone lung surgery 6. Uncontrolled seizures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07183696 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 60 Years, studying Hemodialysis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07183696 currently recruiting?
Yes, NCT07183696 is actively recruiting participants. Contact the research team at info@sameheldaly.online for enrollment information.
Where is the NCT07183696 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT07183696 clinical trial?
NCT07183696 is sponsored by Cairo University. The trial plans to enroll 50 participants.